Home> Products> type 2 diabetes management india

{ "products": [ { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69d4f4af8538099a3d49a36b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 500 mg (Extended Release) Tablets", "description": "Managing type 2 diabetes effectively requires a combination of the right medication, lifestyle changes, and continuous monitoring. GLIDAPA TENMET 500, a powerful triple-combination tablet containing Dapagliflozin (10 mg), Teneligliptin (20 mg), and Metformin Hydrochloride (500 mg), is designed to provide comprehensive glycemic control for individuals suffering from type 2 diabetes mellitus.\n\nThis advanced formulation works through multiple mechanisms to regulate blood sugar levels, improve insulin sensitivity, and reduce glucose production, making it an ideal solution for patients who require combination therapy.\n\nHow GLIDAPA TENMET 500 Works\n\nGLIDAPA TENMET 500 combines three well-established antidiabetic agents, each targeting different pathways:\n\nDapagliflozin works by inhibiting SGLT2 receptors in the kidneys, promoting the excretion of excess glucose through urine.\nTeneligliptin increases incretin hormone levels, which stimulate insulin secretion and decrease glucagon release after meals.\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues.\n\nTogether, this triple-action formula ensures better blood sugar control throughout the day, especially for patients with uncontrolled diabetes on monotherapy.\n\nUses of GLIDAPA TENMET 500\n\nGLIDAPA TENMET 500 is primarily prescribed for:\n\nManagement of Type 2 Diabetes Mellitus\nPatients with inadequate glycemic control on dual therapy\nReducing fasting and postprandial blood glucose levels\nImproving insulin sensitivity\nSupporting weight management in diabetic patients\n\nIt is usually recommended along with a proper diet and regular exercise for optimal results.\n\nKey Benefits of GLIDAPA TENMET 500\n1. Triple Mechanism Action\n\nUnlike single or dual therapy drugs, this combination provides a three-way approach to diabetes control, targeting different physiological processes.\n\n2. Effective Blood Sugar Control\n\nIt helps maintain stable glucose levels throughout the day, reducing spikes after meals.\n\n3. Weight Management Support\n\nDapagliflozin aids in calorie loss through urine, which may help in weight reduction.\n\n4. Cardiovascular Benefits\n\nThis combination may help reduce cardiovascular risks associated with diabetes when used under medical supervision.\n\n5. Low Risk of Hypoglycemia\n\nCompared to some other antidiabetic medications, it has a relatively lower risk of causing dangerously low blood sugar levels.\n\n6. Improved Patient Compliance\n\nCombining three drugs in one tablet reduces pill burden and improves adherence.\n\nDosage and Administration\nTake GLIDAPA TENMET 500 as prescribed by your doctor\nUsually taken once daily with meals to reduce gastrointestinal side effects\nSwallow the tablet whole; do not crush or chew\nFollow your physician’s advice strictly for best results\nSide Effects of GLIDAPA TENMET 500\n\nLike all medications, this combination may cause some side effects. Most are mild and temporary.\n\nCommon Side Effects\nNausea or vomiting\nDiarrhea\nHeadache\nIncreased urination\nNasopharyngitis (cold-like symptoms)\nMild dehydration\nSerious Side Effects (Rare)\nUrinary tract infections\nGenital infections\nLactic acidosis (rare but serious, linked to Metformin)\nHypoglycemia (especially if combined with other medications)\nKidney function changes\n\nIf any severe symptoms occur, immediate medical attention is necessary.\n\nPrecautions and Warnings\nNot recommended for patients with severe kidney disease\nUse cautiously in elderly patients\nAvoid excessive alcohol consumption\nInform your doctor if you have liver, heart, or pancreatic conditions\nNot suitable for type 1 diabetes or diabetic ketoacidosis\n\nPregnant and breastfeeding women should consult a healthcare professional before use.\n\nWho Should Use GLIDAPA TENMET 500?\n\nThis medication is ideal for:\n\nAdults diagnosed with Type 2 Diabetes\nPatients requiring combination therapy\nIndividuals not achieving control with Metformin alone\nOverweight diabetic patients needing additional metabolic benefits\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nGLIDAPA TENMET 500 is a modern, highly effective triple-combination therapy designed to provide comprehensive control over type 2 diabetes. With the combined power of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride, it addresses multiple aspects of glucose metabolism, making it a preferred choice for healthcare professionals.\n\nIts benefits go beyond just blood sugar control—it also supports weight management, improves insulin sensitivity, and enhances overall metabolic health. However, like any medication, it should only be used under proper medical supervision to ensure safety and effectiveness.", "price": 182.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2369, "imageuri": "https://productimages.withfloats.com/actual/69d4f4b2203d41ae56676abb.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d4f4b2203d41ae56676abb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-07T12:12:31.371Z", "updatedon": "2026-04-14T12:54:05.267Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-teneligliptin-20-mg-metformin-hydrochloride-500-mg-extended-release-tablets/2369", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENMET 500", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin teneligliptin metformin combination uses", "metformin teneligliptin dapagliflozin tablets for type 2 diabetes", "buy dapagliflozin teneligliptin metformin tablets online India", "dapagliflozin teneligliptin metformin tablet price wholesale", "SGLT2 + DPP4 + Metformin combination tablet supplier", "anti diabetic triple combination tablets wholesale", "riple combination diabetes medicine manufacturer India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69b3dbf5fe6f1f334a91635f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets", "description": "Managing type 2 diabetes mellitus requires a comprehensive approach that focuses on controlling blood glucose levels, improving insulin sensitivity, and supporting overall metabolic health. With the increasing prevalence of diabetes worldwide, combination therapies have become an effective solution to provide better glycemic control through multiple mechanisms.\n\nGLIDAPA TENMET 1000 is a triple-combination antidiabetic medication formulated with Dapagliflozin, Teneligliptin, and Metformin. This advanced formulation is designed to help individuals with type 2 diabetes manage blood sugar levels more effectively when diet, exercise, and single-drug therapy are not sufficient.\n\nThe combination works through different pathways in the body to regulate glucose levels, improve insulin activity, and reduce excess sugar in the bloodstream. As a result, it helps patients maintain better long-term glycemic control and reduce the risk of diabetes-related complications.\n\nComposition and Mechanism of Action\n1. Dapagliflozin\n\nDapagliflozin belongs to a class of medicines known as SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors). These medications work by preventing the kidneys from reabsorbing glucose back into the bloodstream.\n\nInstead, the excess glucose is removed from the body through urine. This process helps lower blood sugar levels independently of insulin and contributes to improved glycemic control.\n\nIn addition, dapagliflozin may also help in modest weight reduction and improved cardiovascular health in some patients.\n\n2. Teneligliptin\n\nTeneligliptin is part of the DPP-4 inhibitor (Dipeptidyl Peptidase-4 inhibitor) class. It works by increasing the levels of incretin hormones in the body.\n\nIncretin hormones play an important role in blood sugar regulation by:\n\nStimulating insulin release from the pancreas when blood glucose levels rise\n\nReducing the production of glucose by the liver\n\nSlowing gastric emptying\n\nThese effects help maintain stable blood sugar levels after meals.\n\n3. Metformin\n\nMetformin is one of the most widely used medications for type 2 diabetes. It works primarily by:\n\nReducing glucose production in the liver\n\nIncreasing insulin sensitivity in body tissues\n\nImproving the body's ability to utilize glucose\n\nMetformin also helps lower fasting blood sugar levels and supports overall metabolic control.\n\nTogether, these three components create a complementary mechanism of action, making GLIDAPA TENMET 1000 an effective therapy for managing diabetes.\n\nUses of GLIDAPA TENMET 1000\n\nThis medication is primarily prescribed for the management of type 2 diabetes mellitus in adults. It is typically recommended when lifestyle changes and single-drug therapy do not provide adequate blood sugar control.\n\n1. Control of Blood Sugar Levels\n\nGLIDAPA TENMET 1000 helps regulate blood glucose levels throughout the day, including both fasting and post-meal sugar levels.\n\n2. Support for Long-Term Diabetes Management\n\nConsistent use of the medication, along with proper diet and exercise, helps maintain stable blood sugar levels over time.\n\n3. Reduction of Insulin Resistance\n\nMetformin improves the body's sensitivity to insulin, allowing glucose to be utilized more effectively by cells.\n\n4. Elimination of Excess Glucose\n\nDapagliflozin helps remove excess sugar through urine, reducing overall blood glucose levels.\n\n5. Improvement of Post-Meal Sugar Levels\n\nTeneligliptin helps regulate the body’s insulin response after meals, preventing sharp spikes in blood sugar.\n\nKey Benefits of GLIDAPA TENMET 1000\n1. Triple Mechanism for Better Control\n\nThe combination of three antidiabetic agents targets multiple pathways involved in glucose regulation, resulting in more effective blood sugar management.\n\n2. Improved Glycemic Stability\n\nThe medication helps control both fasting and postprandial (after meal) blood glucose levels.\n\n3. Supports Weight Management\n\nUnlike some diabetes medications that may cause weight gain, dapagliflozin may contribute to modest weight reduction in certain individuals.\n\n4. Cardiovascular Support\n\nSGLT2 inhibitors like dapagliflozin have been associated with potential heart health benefits in certain patients with diabetes.\n\n5. Convenient Combination Therapy\n\nInstead of taking multiple medications separately, this single tablet combines three active ingredients, making diabetes management more convenient.\n\n6. Reduced Risk of Diabetes Complications\n\nMaintaining controlled blood sugar levels helps reduce the risk of long-term complications such as nerve damage, kidney disease, and eye problems.\n\nPossible Side Effects\n\nWhile GLIDAPA TENMET 1000 is generally well tolerated, some individuals may experience side effects. These effects are usually mild and temporary but should be monitored.\n\nCommon Side Effects\n\nNausea\n\nStomach upset\n\nDiarrhea\n\nIncreased urination\n\nHeadache\n\nModerate Side Effects\n\nDizziness\n\nUrinary tract infections\n\nLow blood sugar (especially when used with other antidiabetic medications)\n\nFatigue\n\nRare Side Effects\n\nDehydration\n\nSevere gastrointestinal discomfort\n\nAllergic reactions such as rash or itching\n\nLactic acidosis (rare but serious complication associated with metformin)\n\nIf any severe or persistent symptoms occur, medical attention should be sought immediately.\n\nPrecautions\n\nCertain precautions should be considered before using this medication:\n\nThe medicine should only be taken under medical supervision.\n\nPatients with kidney disease or liver disorders should consult their doctor before starting treatment.\n\nAdequate hydration is important while taking SGLT2 inhibitors like dapagliflozin.\n\nAlcohol consumption should be limited, as it may increase the risk of certain side effects.\n\nBlood glucose levels should be monitored regularly to ensure proper control.\n\nPregnant or breastfeeding women should consult a healthcare professional before using this medication.\n\nLifestyle Recommendations for Better Results\n\nFor optimal results, medication should be combined with healthy lifestyle habits, including:\n\nMaintaining a balanced diet low in refined sugars\n\nEngaging in regular physical activity\n\nMonitoring blood glucose levels regularly\n\nMaintaining a healthy body weight\n\nFollowing the doctor’s prescribed treatment plan\n\nLifestyle modifications significantly enhance the effectiveness of diabetes medications.\n\nConclusion\n\nType 2 diabetes is a chronic condition that requires consistent management to prevent long-term complications and maintain overall health. Combination therapies have become an important part of modern diabetes treatment because they target multiple aspects of blood sugar regulation.", "price": 223.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2326, "imageuri": "https://productimages.withfloats.com/actual/69b3dc555c5e1bebb0f137b9.png", "tileimageuri": "https://productimages.withfloats.com/tile/69b3dc555c5e1bebb0f137b9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-13T09:42:13.961Z", "updatedon": "2026-03-14T10:54:48.766Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-teneligliptin-20-mg-metformin-hydrochloride-1000-mg-extended-release-tablets/2326", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENMET 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin 50mg glimepiride 2mg metformin 500mg", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2026-03-13T10:48:17.253Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50mg-glimepiride-2mg-metformin-500mg/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin", "Metformin Hydrochloride", "Glimepiride", "type 2 diabetes mellitus", "sitagliptin 50 mg glimepiride 2 mg metformin 500 mg tablet uses", "sitagliptin glimepiride metformin combination benefits for diabetes", "sitagliptin glimepiride metformin tablet dosage guide", "sitagliptin glimepiride metformin tablets how it works for blood sugar", "sitagliptin glimepiride metformin tablets doctor prescription guide", "buy sitagliptin glimepiride metformin tablets online", "sitagliptin glimepiride metformin tablet price in india", "sitagliptin glimepiride metformin tablets supplier", "sitagliptin glimepiride metformin tablets supplier", "who should take sitagliptin glimepiride metformin tablets", "sitagliptin glimepiride metformin tablets weight loss effect", "sitagliptin glimepiride metformin tablets kidney safety" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "683d992c87328f4e892f8716", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 25 mg", "description": "EMPATECH 25 is an advanced oral medication formulated with Empagliflozin 25 mg, a trusted and effective treatment for managing Type 2 Diabetes Mellitus (T2DM). It is part of a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), designed to help lower blood sugar levels in adults when used alongside proper diet and exercise. EMPATECH 25 not only improves glycemic control but also contributes to weight management and cardiovascular health in diabetic patients.\n\nKey Ingredients\nEmpagliflozin 25 mg: A selective SGLT2 inhibitor that helps remove excess glucose from the body through urine, lowering blood sugar levels in patients with type 2 diabetes.\n\nKey Benefits\nHelps significantly reduce elevated blood glucose (HbA1c) levels in Type 2 Diabetes\n\nSupports weight loss by reducing excess sugar stored in the body\n\nAids in lowering systolic blood pressure\n\nDemonstrated cardiovascular benefits, including reduced risk of heart failure hospitalization\n\nEnhances overall glycemic control without causing hypoglycemia when used alone\n\nConvenient once-daily oral dosing\n\nHow Does It Work?\nEmpagliflozin blocks the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream.\n\nBy inhibiting this protein, the medication increases glucose excretion through urine, thereby lowering blood sugar levels.\n\nIt works independently of insulin, making it a suitable option even when insulin resistance is present.\n\nAdditionally, this mechanism reduces blood pressure and body weight, offering multiple metabolic benefits beyond blood sugar control.\n\nDirections for Use\nTake one tablet of EMPATECH 25 orally once a day, preferably at the same time each day.\n\nIt can be taken with or without food.\n\nFollow the dosage as prescribed by your healthcare provider.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\nMaintain regular blood sugar monitoring and adhere to a balanced diet and exercise regimen.\n\nSide Effects\nIncreased urination\n\nGenital infections (e.g., yeast infections)\n\nUrinary tract infections (UTIs)\n\nThirst and mild dehydration\n\nLow blood pressure (especially in people on diuretics)\n\nDizziness or lightheadedness\n\nPossible increase in cholesterol levels\n\nIn rare cases, ketoacidosis (seek immediate medical attention if symptoms like nausea, vomiting, or abdominal pain occur)", "price": 211.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet swallow", "day preferably", "body aids", "nausea vomiting", "medical attention", "cholesterol levels", "diuretics dizziness", "crush chew", "healthcare provider", "food follow", "empatech 25 orally", "present additionally", "insulin resistance", "suitable option", "insulin making", "works independently", "sglt2 protein", "causing hypoglycemia", "reduced risk", "cardiovascular health", "weight management", "exercise empatech 25", "effective treatment", "empatech 25empatech 25", "balanced diet", "empagliflozin 25 mg", "glycemic control", "improves glycemic control", "work empagliflozin blocks", "selective sglt2 inhibitor", "alongside proper diet", "abdominal pain occur", "reabsorbing glucose back" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2130, "imageuri": "https://productimages.withfloats.com/actual/683d99313e1ed3094cddca21.png", "tileimageuri": "https://productimages.withfloats.com/tile/683d99313e1ed3094cddca21.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-02T12:29:32.123Z", "updatedon": "2026-03-13T10:22:19.583Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-25-mg/2130", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH 25", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 25 mg", "empagliflozin 25 mg tablet", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India", "blood sugar levels.", "help lower blood sugar.", "cardiovascular health in diabetic patients." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 12.5mg, Metformin Hydrochloride 500mg", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\nFollow a balanced diet and regular exercise regimen for optimal results.\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\nSide Effects:\n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\nUrinary Tract Infections (UTIs) due to increased glucose in urine\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 145.0, "discountamount": 44.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2026-03-13T09:41:22.601Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-12-5mg-metformin-hydrochloride-500mg/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "674b0a7ee34075b8291b14f1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride 0.5 mg, Voglibose 0.2 mg & Metformin Hydrochloride (SR) 500 mg Tablets", "description": "Diabetes management often requires a multifaceted approach to address the complexities of glucose regulation. Glimiteris Trio 0.5/0.2/500 offers a synergistic combination of three proven antidiabetic agents. This tablet not only targets fasting and postprandial blood glucose but also improves the body’s insulin utilization, ensuring better glycemic control and reducing the risk of complications associated with diabetes.\n\n \nKey Benefits:\nEffective Blood Sugar Management: Works on multiple pathways to control both fasting and postprandial blood glucose levels.\nReduces Insulin Resistance: Enhances the body's response to insulin, improving its efficacy.\nMinimizes Post-Meal Glucose Spikes: Voglibose slows carbohydrate digestion and absorption, keeping postprandial glucose in check.\nImproves Long-Term Glycemic Control: Helps in achieving and maintaining stable HbA1c levels.\nSustained Release Formula: Metformin’s SR formulation ensures prolonged action, reducing the need for frequent dosing.\nComprehensive Diabetes Management: Prevents complications like neuropathy, retinopathy, and cardiovascular issues associated with diabetes.\nHow Does It Work?\nGlimepiride: Stimulates the pancreas to release insulin, directly lowering blood glucose levels.\nVoglibose: Inhibits enzymes that break down carbohydrates into glucose, thereby delaying glucose absorption and controlling post-meal spikes.\nMetformin Hydrochloride SR: Decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, ensuring balanced glucose levels throughout the day.\nTogether, these three ingredients address the multifaceted nature of type 2 diabetes, providing a holistic solution for effective blood sugar control.\n\nDirections for Use:\nDosage: Take one tablet as prescribed by your healthcare professional, usually once or twice daily with meals.\nSwallow Whole: Do not crush or chew the tablet; it is designed for sustained release.\nTiming: Preferably consume with a meal to reduce gastrointestinal discomfort and optimize efficacy.\nFollow Medical Advice: Stick to the prescribed dosage and schedule for optimal results.\nAlways consult your doctor before starting or adjusting your dosage.\n\nSide Effects:\nWhile Glimiteris Trio 0.5/0.2/500 is generally well-tolerated, some individuals may experience side effects, including:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nStomach discomfort or flatulence\nMild hypoglycemia (low blood sugar levels)\nRare but Serious Side Effects:\n\nSevere hypoglycemia\nLactic acidosis (from Metformin)\nAllergic reactions such as rash or itching\n\n", "price": 153.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "prescribed dosage", "ingredients address", "glycemic control", "targets fasting", "generally welltolerated", "glimiteris trio 0502500", "optimal results", "meals swallow", "healthcare professional", "holistic solution", "multifaceted nature", "cardiovascular issues", "neuropathy retinopathy", "insulin improving", "bodys response", "multiple pathways", "synergistic combination", "multifaceted approach", "dosage side effects", "delaying glucose absorption", "postprandial blood glucose", "metformin allergic reactions", "diarrhea stomach discomfort", "experience side effects", "reduce gastrointestinal discomfort", "work glimepiride stimulates", "proven antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2016, "imageuri": "https://productimages.withfloats.com/actual/674b0a80ec7bb8b7dcae8a8a.png", "tileimageuri": "https://productimages.withfloats.com/tile/674b0a80ec7bb8b7dcae8a8a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-11-30T12:52:14.799Z", "updatedon": "2026-03-26T05:47:46.878Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-0-5-mg-voglibose-0-2-mg-metformin-hydrochloride-sr-500-mg-tablets/2016", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS TRIO 0.5/0.2/500 ", "category": "DIABETIC RANGE", "tags": [ "Glimepiride 0.5 mg, Voglibose 0.2 mg & Metformin Hydrochloride (SR) 500 mg Tablets", "blood glucose", "diabetes." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66d6fe913838c070275d07c9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIBENCLAMIDE IP 2.5mg, METFORMIN HYDROCHLORIDE IP 400mg", "description": "GLIBIMIDE M 2.5 /400 \nGLIBENCLAMIDE IP 2.5mg, METFORMIN HYDROCHLORIDE IP 400mg\nGLIBIMIDE M 2.5 / 400 is a potent combination medication formulated to help manage type 2 diabetes effectively. It combines the therapeutic benefits of Glibenclamide IP 2.5mg and Metformin Hydrochloride IP 400mg. This medication is designed to help control blood sugar levels, reduce the risk of complications associated with diabetes, and improve overall health. It is available at an attractive price of Rs 35.00, with a 30% discount from the MRP of Rs 50.00, inclusive of all taxes.\n\n \n\nKey Ingredients:\n \n\nGlibenclamide IP 2.5mg: Glibenclamide is a sulfonylurea class drug that stimulates the pancreas to release insulin, helping to lower blood glucose levels.\nMetformin Hydrochloride IP 400mg: Metformin belongs to the biguanide class and works by reducing glucose production in the liver and improving the body's sensitivity to insulin.\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: GLIBIMIDE M 2.5 / 400 effectively lowers high blood sugar levels in patients with type 2 diabetes, helping to prevent long-term complications.\nDual Action Formula: The combination of Glibenclamide and Metformin offers a synergistic effect, enhancing glucose control by both increasing insulin production and reducing glucose production in the liver.\nImproves Insulin Sensitivity: Metformin, one of the key ingredients, improves the body’s response to insulin, ensuring more effective management of blood sugar levels.\nReduces Risk of Diabetes Complications: By maintaining optimal blood glucose levels, GLIBIMIDE M 2.5 / 400 helps reduce the risk of complications such as neuropathy, nephropathy, and cardiovascular issues.\n \n\nHow Does It Work?\n \n\nGLIBIMIDE M 2.5 / 400 works through a two-pronged approach:\n\nGlibenclamide stimulates the pancreas to release more insulin, which helps lower blood sugar levels after meals.\nMetformin works by decreasing the amount of glucose produced by the liver and improving the sensitivity of muscle cells to insulin, allowing them to take in more glucose.\nThis dual mechanism ensures better blood sugar control throughout the day.\n\n \n\nDirections for Use:\n \n\nTake GLIBIMIDE M 2.5 / 400 exactly as prescribed by your healthcare provider. Typically, it is taken once or twice daily with meals to reduce the risk of stomach upset and to enhance its effectiveness. Swallow the tablet whole with water, without crushing or chewing it. It's important to follow your doctor's instructions closely to achieve optimal results.\n\n \n\nSide Effects:\n \n\nWhile GLIBIMIDE M 2.5 / 400 is generally well-tolerated, some patients may experience side effects, including:\n\nHypoglycemia (Low Blood Sugar): Symptoms may include dizziness, sweating, shakiness, and confusion. It is important to monitor blood sugar levels regularly.\nGastrointestinal Issues: Common side effects related to Metformin may include nausea, vomiting, diarrhea, and abdominal discomfort.\nAllergic Reactions: Rarely, some individuals may experience allergic reactions such as rash, itching, or swelling. Seek medical attention if these occur.\nWeight Gain: Glibenclamide may cause a slight increase in weight.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 50.0, "discountamount": 15.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "400 works", "Weight Gain", "GLIBIMIDE M", "30% discount", "muscle cells", "Key Benefits", "stomach upset", "overall health", "dual mechanism", "type 2 diabetes", "slight increase", "Key Ingredients", "biguanide class", "optimal results", "glucose control", "Low Blood Sugar", "attractive price", "GLIBENCLAMIDE IP", "medical attention", "insulin production", "Allergic Reactions", "synergistic effect", "glucose production", "Insulin Sensitivity", "healthcare provider", "Common side effects", "Dual Action Formula", "abdominal discomfort", "two-pronged approach", "therapeutic benefits", "effective management", "cardiovascular issues", "Diabetes Complications", "long-term complications", "Gastrointestinal Issues", "sulfonylurea class drug", "high blood sugar levels", "optimal blood glucose levels", "potent combination medication", "Effective Blood Sugar Control", "Metformin Hydrochloride IP 400mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1955, "imageuri": "https://productimages.withfloats.com/actual/66d6fea3e41b5cdcdef61e36.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d6fea3e41b5cdcdef61e36.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T12:18:25.8Z", "updatedon": "2026-03-13T09:16:40.221Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glibenclamide-ip-2-5mg-metformin-hydrochloride-ip-400mg/1955", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIBIMIDE M 2.5 /400", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2026-03-26T05:46:52.891Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }